The SIGNIFY trial is testing the hypothesis that treatment with ivabradine reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure.
http://www.signify-study.org/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
2.3 seconds
BIOFARMA
Domain Manager
50 r●●●●rnot
SUR●●●NES , cedex, 92284
FR
View this contact
BIOFARMA
Domain Manager
50 r●●●●rnot
SUR●●●NES , cedex, 92284
FR
View this contact
MarkMonitor
Domain Admin
PM●●55
Bo●●se , ID, 83709-1433
US
View this contact
BUY YOUR DOMAIN
MarkMonitor Inc. (R37-LROR)
WHOIS : whois.publicinterestregistry.net
REFERRED :
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
0
SITE IP
92.103.89.165
LOAD TIME
2.297 sec
SCORE
6.2
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease | signify-study.org Reviews
https://signify-study.org
The SIGNIFY trial is testing the hypothesis that treatment with ivabradine reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure.
signify-study.org
Prof Kim Fox (Chair) - SIGNIFY
http://www.signify-study.org/committees-and-investigators/executive-committee/prof-kim-fox-chair
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. Raquo; Committees and Investigators. Raquo; Executive Committee. Raquo; Prof Kim Fox (Chair). Prof Kim Fox (Chair). National Heart and Lung Institute. Professor Fox has published 400 papers in leading scientific journals. His expertise is in the understanding, investigation, and treatment of angina, and he has played a major role in international clinical trials (TIBET, ...
TOTAL PAGES IN THIS WEBSITE
1
Blog de signify-nothing - #♀♂ *Lulu ♀♂-' - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. 9792;♂ *Lulu ♀♂-'. Ben c'est un blog comme tous les autres c'est tout mais si t'aime pas ben casse toi c'est simple :). 9834; (♥). Réunion (Île de la). Mise à jour :. Lulu-w0rld.sky' Et ouii les temps change. Abonne-toi à mon blog! T ouii les temps change . T les gens aussi. E m'en vais . Aite pétés les com's. Ur le nouveau blog ;). Hanger vos blogs fav'. Ou poster avec :. Posté le mercredi 05 décembre 2007 10:10. S des trucs tr. Is ça va =D. Ou poster avec :.
Welcome to Signify Signs
Skip to main content. Signify Vehicle Wraps are a great way to stand out from the crowd and get noticed. Take your brand to the streets! Signify carries a wide array of Indoor Signage Products to make sure your brand stands out and is seen. Signify carries a wide array of Outdoor Signage Products to make sure you’re seen, out and about. Of course we do that! Signify Signs offers a wide. Variety of products and. Services. Got a custom signage. Office Lobby and Building Directory. Take it to the streets!
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
Signify.at
Default Parallels Plesk Panel Page
Web Server's Default Page. This page is generated by Parallels Plesk Panel. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Parallels Plesk Panel. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms.
